Recently, Ising et al. suggested that the link between Aβ and Tau pathologies in AD is represented by NLRP3 inflammasome, and at least one signalling pathway interacting with both Aβ and Tau has been identified, which is the TREM2-TYROBP pathway [45,61]. Here, MAPT is linked to Alzheimer disease.